Similarly, LY6D may impact bladder cancer progression indirectly through complex interactions involving non-coding RNAs or protein complexes, nuances that single-variant-focused methods like SMR analysis might miss 27, 45. This evidence concerns the gene LY6D and urinary bladder carcinoma.